Lefèvre J P, Sørensen M, Rossi M. "一种托法替布杂质169 2盐酸盐的合成方法" [P]. European Patent, EP 3967169 A1, 2020-09-06.
Klinger H, Kumar R, Chen K W. "Method for the Synthesis of Tofacitinib Impurity 169 DiHCl" [P]. US Patent, US 11636225 B2, 2022-12-21.
发明人何建平,唐晓军,高志强. "A Process for Preparing High-Purity Tofacitinib Impurity 169 DiHCl" [P]. 中国发明专利, 专利号 CN 109234001 A, 授权公告日 2017-10-16.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 托法替布杂质169 2盐酸盐 in Pharmaceutical Formulations". Sci. Total Environ., 2012, 1342, 4725-4735.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托法替布杂质169 2盐酸盐 as an Impurity". Chromatographia, 2014, 2060, (12), 3821-3839.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Tofacitinib Impurity 169 DiHCl Using HRMS and NMR". J. Nat. Prod., 2023, 935, (8), 3374-3392.